Oberacher-Velten, I. ; Helbig, H.
Alternative Links zum Volltext:DOIVerlag
| Dokumentenart: | Artikel |
|---|
| Titel eines Journals oder einer Zeitschrift: | Klinische Monatsblätter für Augenheilkunde |
|---|
| Verlag: | GEORG THIEME VERLAG KG |
|---|
| Ort der Veröffentlichung: | STUTTGART |
|---|
| Band: | 227 |
|---|
| Nummer des Zeitschriftenheftes oder des Kapitels: | 09 |
|---|
| Seitenbereich: | S. 694-700 |
|---|
| Datum: | 2010 |
|---|
| Institutionen: | Medizin > Lehrstuhl für Augenheilkunde |
|---|
| Identifikationsnummer: | | Wert | Typ |
|---|
| 10.1055/s-0029-1245717 | DOI |
|
|---|
| Stichwörter / Keywords: | DIODE-LASER PHOTOCOAGULATION; ENDOTHELIAL GROWTH-FACTOR; THRESHOLD RETINOPATHY; INTRAVITREAL BEVACIZUMAB; MULTICENTER TRIAL; ZONE-I; CRYOTHERAPY; ROP; POPULATION; INJECTION; retinopathy of prematurity; anti-VEGF; bevacizumab; vascular endothelial growth factor |
|---|
| Dewey-Dezimal-Klassifikation: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin |
|---|
| Status: | Veröffentlicht |
|---|
| Begutachtet: | Ja, diese Version wurde begutachtet |
|---|
| An der Universität Regensburg entstanden: | Ja |
|---|
| Dokumenten-ID: | 65827 |
|---|
Web of Science
Zusammenfassung
Retinopathy of prematurity (ROP) is one of the three leading causes of legal blindness in childhood in the developed countries. Improved neonatal care has resulted in the increased survival of extremely immature infants at high risk to develop ROP. Current treatment for ROP with laser may prevent blindness by causing involution of pathological vessels and thus inhibit the development of retinal ...
Zusammenfassung
Retinopathy of prematurity (ROP) is one of the three leading causes of legal blindness in childhood in the developed countries. Improved neonatal care has resulted in the increased survival of extremely immature infants at high risk to develop ROP. Current treatment for ROP with laser may prevent blindness by causing involution of pathological vessels and thus inhibit the development of retinal detachment. But this coagulation of the avascular retina is a destructive therapy and does not otherwise ameliorate retinal development. Recent reports have described vascular endothelial growth factor antibodies as therapy for ROP. This article reports our own experience with this new therapy and gives an overview of the recent literature.
Altmetric